Viewing StudyNCT04136366



Ignite Creation Date: 2024-05-06 @ 1:48 PM
Last Modification Date: 2024-10-26 @ 1:20 PM
Study NCT ID: NCT04136366
Status: COMPLETED
Last Update Posted: 2023-06-02
First Post: 2019-10-21

Brief Title: The GUARD Trial - Part 1 A Phase 3 Clinical Trial for Prevention of Proliferative Vitreoretinopathy
Sponsor: Aldeyra Therapeutics Inc
Organization: Aldeyra Therapeutics Inc

Conditions & Keywords Data

Conditions:
Name
Proliferative Vitreoretinopathy
Keywords:
Name View
open globe injury View
ADX-2191 View
recurrent retinal detachment View